Skip to main content
. Author manuscript; available in PMC: 2024 Nov 13.
Published in final edited form as: Immunology. 2022 Mar 31;166(3):310–326. doi: 10.1111/imm.13473

FIGURE 7.

FIGURE 7

IL4 mediated Trat1 expression enhances Tc17 anti-tumour phenotype. The IL-4/AKT/Eomes/Trat1 axis is a novel signalling loop that promotes expansion and reprogramming of Tc17 cells into cytotoxic effectors with a therapeutic potential for adoptive cell transfer immunotherapy